Wallac's oestriol immunoassay:
This article was originally published in Clinica
Wallac of Finland's recently-launched assay for monitoring foetal well-being is AutoDELFIA Unconjugated Estriol - and not Estradiol, as stated in Clinica No 668 (p 18). Based on the DELFIA immunoassay technique, the kit is used with the company's AutoDELFIA automatic immunoassay system to measure oestriol.
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.